Navigation Links
Live Coverage of 2011 Nobel Prize Announcements and Exclusive Content on Nobelprize.org
Date:9/28/2011

STOCKHOLM, September 28, 2011 /PRNewswire/ --

Nobelprize.org provides the official news about the 2011 Nobel Prize announcements within Physiology or Medicine, Physics, Chemistry, Literature, Peace and the Prize in Economic Sciences as soon as they happen. The first announcement, for the Nobel Prize in Physiology or Medicine, will be made on 3 October 11:30 a.m. CET, 9:30 a.m. GMT at the earliest (see the full timetable of announcements).

http://www.nobelprize.org/nobel_prizes/about/prize_announcements/

Background information about the new Nobel Laureates and their Nobel Prize awarded achievements, and official press releases from the Nobel Prize awarding institutions, will be immediately posted.

You can follow the news in the several ways:

Live webcast on Nobelprize.org. The press conferences from the Nobel Prize awarding institutions and exclusive interviews with members of Nobel Committees will be webcast live.

Live video player. You can embed the live video player http://www.nobelprize.org/nobel_prizes/about/prize_announcements/ on your own web site or blog for up-to-the-minute news as they occur.

Video on-demand. If you cannot follow the live webcast, the announcements as well as interviews will be available as downloadable video on-demand after a few hours.  New this year, on demand streaming is available to support all mobile devices such as phones and tablets.

Social media. Keep up with the latest news on the Nobelprize.org Facebook page, http://www.facebook.com/Nobelprize.org. The Twitter feed http://twitter.com/Nobelprize_org(#nobelprize) lets you keep in touch with the Nobel Prize announcements using the web, through SMS alerts on your phone, or instant messenger services.

Exclusive content. Nobelprize.org conducts a telephone interview with the 2011 Nobel Laureates immediately after they receive the news about the Nobel Prize capturing the Laureates' first impressions about the announcement.

About Nobelprize.org and Nobel Media AB

Nobelprize.orgis managed by Nobel MediaAB, the company responsible for managing and developing media rights in connection with the Nobel Prize. Nobel Media aims to spread knowledge and interest in the Nobel Prize awarded achievements to a global audience, through digital and broadcast media, publishing and events.

Please visit: http://www.nobelprize.org/, @Nobelprize_org on Twitter, http://www.facebook.com/Nobelprize.org, http://www.youtube.com/nobelprize

Nobel Media®, Nobel Prize® and Nobelprize.org® are registered trademarks of the Nobel Foundation.

Disclaimer: Nobel Media AB is not directly or indirectly involved in the process of nominating or selecting Nobel Laureates. These procedures are strictly confidential and regulated by the Nobel Prize awarding institutions.


'/>"/>
SOURCE Nobelprize.org
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Local Medicare Contractors Expand Hypertension Coverage for CardioDynamics BioZ(R) ICG Technology
2. Lack of Medicare Part D Coverage for All Medically Necessary Prescriptions Endangers Older Americans and Those with Chronic Diseases and Disabilities
3. Initiation of Coverage Informational Review Issued by Scimitar Equity Research
4. Medicare Announces Expanded Coverage for Warfarin Patients Monitoring Clotting Time at Home
5. Medicare Announces Expanded Coverage for Anticoagulation Patients, Opening the Door for More Patients to Test PT/INR at Home
6. Advaxis, Inc Initiation Coverage Review Issued By Scimitar Equity, LLC
7. Online Coverage of International AIDS Conference Includes Daily Webcasts, Podcasts and Interviews
8. Generex Biotechnology Corporation Initiation Coverage Review Issued By Scimitar Equity, LLC
9. Essentialis Meets Primary Endpoint in Phase 2b Trial of DCCR for Treatment of Hypertriglyceridemia and is Granted Extensive Patent Coverage in the US
10. Data Presented on Cempra Pharmaceuticals CEM-101 at the Infectious Diseases Society of America Annual Meeting Reinforces Potency and Coverage Against Multidrug-Resistant S. Pneumoniae Isolates
11. WJB Capital Group, Inc. Expands Coverage of Healthcare Industry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... --  Arena Pharmaceuticals, Inc. (NASDAQ: ARNA ... the ralinepag phase 2 trial.  Ralinepag is an oral, ... the treatment of pulmonary arterial hypertension (PAH). The study ... "This marks an important step in the development of ... our pipeline," said Amit Munshi , Arena,s President ...
(Date:12/7/2016)... , Dec. 7, 2016   TraceLink Inc ... for connecting the Life Sciences supply chain and ... today announced that Tjoapack has selected TraceLink,s serialization ... customers comply with the rapidly approaching serialization deadlines ... (DSCSA) in 2017 and the EU Falsified Medicines ...
(Date:12/7/2016)... ZIONA SCIENCE PARK , ... biotechnology company Kadimastem (TASE: KDST) announced today the signing of a ... collaboration between the companies. The synergy between the companies will assist ... collaboration as a worldwide leader in innovative treatment for severe diseases ... ...
Breaking Medicine Technology:
(Date:12/7/2016)... TX (PRWEB) , ... December 07, 2016 , ... ... 2016 Top 20 Marketing Campaign Winner in the Folio: Marketing Awards competition. Live ... recognize the year’s best in pioneering, inventive, and ultimately successful projects undertaken by ...
(Date:12/7/2016)... Scottsdale, AZ (PRWEB) , ... ... ... pioneer, ElectroMedical Technologies, announced its newest portable bioelectronic medicine device WellnessPro Plus ... , WellnessPro Plus substantially enhances the WellnessPro platform by expanding the treatment ...
(Date:12/7/2016)... ... 2016 , ... “Walking With God: Inspirational Lessons from My Life's Journey”: ... be aware of God's direction in their lives. “Walking With God: Inspirational Lessons from ... active church leader. , Sanford says, “I enjoy sharing the true stories ...
(Date:12/7/2016)... ... December 07, 2016 , ... Dr. Greg Leyer, the ... Probiotic Association’s Washington DC workshop on November 2nd. The conference was an opportunity ... probiotic dietary supplement regulations. , Dr. Leyer spoke about two main topics ...
(Date:12/6/2016)... ... 2016 , ... The International Vaccine Institute (IVI) and GeneOne ... Middle East Respiratory Syndrome Coronavirus (MERS-CoV). The collaboration will accelerate MERS-CoV vaccine development ... in the event of a future outbreak. , IVI and GeneOne held a ...
Breaking Medicine News(10 mins):